Pricing Log in Create free account
Saturday 17 October 2026 Export CRL’s income statement to Excel — free account

Charles River Laboratories International, Inc.

CRL Healthcare Diagnostics & Research

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024. In the quarter to June 2026, revenue fell 2.72%, EPS fell 102.8%, free cash flow fell 12.2% and total debt rose 12.3%, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

299.77 6.47 −2.11%
Market cap
$14.6B
P/E
0.0×
Fwd P/E
29.6×
Dividend yield
—
F-score
5/9
Altman Z
2.40
Beneish M
−3.11
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Charles River Laboratories International, Inc. (CRL) Revenue

Alert me on Revenue

Charles River Laboratories International, Inc.'s revenue for fiscal 2025 was $4.0B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $4.0B. Over the past ten years it has ranged from $1.4B (fiscal 2015) to $4.1B (fiscal 2023); the current reading is higher than 82% of that period. Charles River Laboratories International, Inc. ranks 12th of 50 Diagnostics & Research companies by revenue.

Revenue, annual

Embed this chart

Annual newest first

Period Revenue Change
FY2025 $4.0B (0.85%)
FY2024 $4.0B (1.92%)
FY2023 $4.1B 3.86%
FY2022 $4.0B 12.31%
FY2021 $3.5B 21.08%
FY2020 $2.9B 11.55%
FY2019 $2.6B 15.67%
FY2018 $2.3B 21.99%
FY2017 $1.9B 10.48%
FY2016 $1.7B 23.34%

Quarterly newest first

Period Revenue Change
Jun 2026 $1.0B 0.83%
Mar 2026 $995.8M 0.16%
Dec 2025 $994.2M (1.06%)
Sep 2025 $1.0B (2.64%)
42 more quarters

Against its own ten years

Low $1.4B High $4.1B
Ten-year median $2.9B
Current reading's percentile 82

Revenue against peers

Company Revenue
LH Labcorp Holdings Inc. compare $14.3B
DGX Quest Diagnostics Incorporated compare $11.6B
ICLR ICON PLC compare $8.3B
CRL Charles River Laboratories International, Inc. $4.0B
RVTY Revvity Inc. compare $2.9B
MEDP Medpace Holdings, Inc. compare $2.8B
QGEN QIAGEN N.V. compare $2.1B
GH Guardant Health, Inc. compare $1.2B
TWST Twist Bioscience Corporation compare $431.8M

What Revenue is

Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.

Reported line item

The full definition of Revenue →

More on CRL